Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds used for bone engineering

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Porous scaffolds are crucial for bone tissue engineering to facilitate cell and tissue interactions.
• Poly(lactide-co-glycolide)-calcium phosphate (PLGA-CaP) scaffolds offer tunable pore sizes for optimizing bone regeneration.

Purpose of the Study:

• To evaluate the impact of varying pore diameters in PLGA-CaP scaffolds on osteoblastic cell responses and bone tissue formation.
• To determine the optimal scaffold pore size for enhanced bone healing in a rat calvarial defect model.

Main Methods:

• PLGA-CaP scaffolds with 85% porosity and pore diameters of 470-590 µm, 590-850 µm, and 850-1200 µm were fabricated.
• Osteogenic differentiation of rat bone marrow stem cells on scaffolds was assessed via cell growth, alkaline phosphatase (ALP) activity, and gene expression.
• Scaffolds were implanted into critical-size rat calvarial defects, followed by histomorphometric analysis at 2, 4, and 8 weeks.

Main Results:

• Cell growth and ALP activity were independent of scaffold pore size.
• Increased pore size correlated with higher gene expression of osteoblastic markers.
• Scaffolds with smaller pores (470-590 µm) demonstrated significantly enhanced bone and blood vessel formation at 4 and 8 weeks post-implantation.

Conclusions:

• PLGA-CaP scaffolds show promise for bone tissue engineering.
• While larger pores upregulate osteogenic gene expression, smaller pores (470-590 µm) are more effective in promoting bone and vascularization in vivo.
• A combination of larger and smaller pores within a single scaffold may offer optimal conditions for bone healing.